Business Context and Reporting Period
MiMedx Group, Inc. filed a Form 8-K on June 10, 2019, reporting the entry into a material definitive agreement. The company is incorporated in Florida and maintains its principal executive offices in Marietta, Georgia.
Key Financial Metrics and Debt Structure
The filing details a new Term Loan Facility with the following characteristics:
- Total Principal Amount: $75,000,000 (fully funded on the Closing Date).
- Interest Rate: LIBOR plus 8.00% per annum, or Prime Rate plus 7.00% per annum if LIBOR is unavailable.
- Repayment Schedule: Equal quarterly installments of $937,500, with the remaining balance due three years after the Closing Date.
- Use of Proceeds: Working capital, general corporate purposes, and payment of transaction fees and expenses.
- Equity Issuance: The agreement does not provide for the issuance of warrants or other equity interests.
Material Changes and Covenants
The primary material change is the incurrence of $75 million in new debt. The Loan Agreement imposes several restrictive covenants and obligations:
- Financial Covenants: Includes a maximum total leverage ratio and minimum liquidity requirements.
- Negative Covenants: Limits on incurring additional indebtedness, making investments, incurring liens, paying dividends, and engaging in mergers, consolidations, or asset dispositions.
- Mandatory Prepayments: Required from proceeds of asset dispositions, events of loss, non-ordinary course cash receipts, equity issuances, and impermissible indebtedness.
- Events of Default: Standard events of default apply, which may trigger immediate repayment of obligations.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, revenue projections, or management commentary regarding future operational performance. The document explicitly states that representations and warranties were made solely for the benefit of the contracting parties and should not be relied upon as characterizations of the company's actual state of facts. Investors are cautioned that information regarding the company's condition may change after the agreement date.
Investor Verification Checklist
- Verify the company's current liquidity position to ensure compliance with the new minimum liquidity covenant.
- Review the full text of the Loan Agreement (Exhibit 10.1) for specific definitions of "maximum total leverage ratio" and permitted exceptions to negative covenants.
- Monitor future filings for any mandatory prepayment events triggered by asset dispositions or equity issuances.
- Assess the impact of the 8.00% LIBOR margin on future interest expense relative to the company's cash flow generation.